Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|35|3921-3931

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.35, 2010-12, pp. : 3921-3931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rational Combination of Targeted Therapies As A Strategy to Overcome The Mechanisms of Resistance to Inhibitors of EGFR Signaling

By  

Current Pharmaceutical Design, Vol. 13, Iss. 33, 2007-11 ,pp. : 3358-3367

Bentham Science Publishers

Access to resources Recommend Favorite

Combination pharmaceutical therapies for obesity

By Gadde Kishore M   Allison David B  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 921-925

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of cancer

By Rhee Jay   Hoff Paulo M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1701-1711

Informa Healthcare

Access to resources Recommend Favorite

New setback for angiogenesis inhibitors

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Breakthrough for angiogenesis inhibitors

By  

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite